Skip to content

Renal Arterial Spin Labelling in chronic Kidney disease

Renal arterial spin labelling in chronic kidney disease: a cross over study of vitamin C versus normal saline

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12301736
Enrollment
36
Registered
2013-12-18
Start date
2013-07-05
Completion date
Unknown
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal, Kidney perfusion, Magnetic resonance imaging Urological and Genital Diseases Chronic kidney disease

Interventions

Sponsors

NHS Greater Glasgow and Clyde (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years 2. Written informed consent 3. CKD - people with chronic kidney disease stages 3 - 5, with an eGFR 15-30ml/min 4. LKD - people being assessed to act as live kidney donors 5. RVD - people with renovascular disease documented on imaging and after assessment by a nephrologist

Exclusion criteria

Exclusion criteria: 1. Known liver disease (alcoholic liver disease, hepatitis, cirrhosis) 2. Known HIV infection 3. Known recreational drug or alcohol abuse 4. Clinical signs of acute infection 5. Known pregnancy 6. Women of childbearing age are who are at risk of pregnancy 7. Metal prosthesis contraindicating MRI 8. Claustrophobia contraindicating MRI

Design outcomes

Primary

MeasureTime frame
Change in renal perfusion by ASL MRI, measured after saline and then after ascorbic acid

Secondary

MeasureTime frame
Biomarkers of oxidative stress both measured after saline and then after ascorbic acid 1. Total antioxidant capacity measured by colorimetric assay 2. Rate of reactive oxygen species generation measured by electron paramagnetic resonance

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026